Search research articles
Contact Us
Filters
Showing results (51-60 of 104) with videos related to
Page
of 11
Sort By:
Frontiers in Oncology
|
January 24, 2022
Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations
Natali Pflug, Annika Littauer, David Beverungen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation
Ann-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Blood Advances
|
April 5, 2022
Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation
Marius Bill, Madlen Jentzsch, Lara Bischof, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
BMC Genomics
|
November 9, 2012
Methods for high-throughput MethylCap-Seq data analysis
Benjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Cell Death & Disease
|
July 28, 2018
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
Jens-Uwe Hartmann, Daniela Bräuer-Hartmann, Miroslava Kardosova, et al.
Science Signaling
|
April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway
Ann-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Bone Marrow Transplantation
|
February 19, 2022
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15
Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke, et al.
Nature Communications
|
July 1, 2017
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation
Alexander Arthur Wurm, Polina Zjablovskaja, Miroslava Kardosova, et al.
Journal of Cancer Research and Clinical Oncology
|
May 24, 2017
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV)
Hannah Tessenow, Madlen Holzvogt, Bruno Holzvogt, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 104) with videos related to
Sort By:
Page
of 11
Frontiers in Oncology
|
January 24, 2022
Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations
Natali Pflug, Annika Littauer, David Beverungen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation
Ann-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Blood Advances
|
April 5, 2022
Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation
Marius Bill, Madlen Jentzsch, Lara Bischof, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
BMC Genomics
|
November 9, 2012
Methods for high-throughput MethylCap-Seq data analysis
Benjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Cell Death & Disease
|
July 28, 2018
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
Jens-Uwe Hartmann, Daniela Bräuer-Hartmann, Miroslava Kardosova, et al.
Science Signaling
|
April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway
Ann-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Bone Marrow Transplantation
|
February 19, 2022
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15
Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke, et al.
Nature Communications
|
July 1, 2017
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation
Alexander Arthur Wurm, Polina Zjablovskaja, Miroslava Kardosova, et al.
Journal of Cancer Research and Clinical Oncology
|
May 24, 2017
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV)
Hannah Tessenow, Madlen Holzvogt, Bruno Holzvogt, et al.
Page
of 11